ClinicalTrials.gov
public full text
Public Domain
Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to <36 Weeks Gestational Age
The primary objective of this study is to characterize the safety, and efficacy of Dexmedetomidine (DEX) administered as an intravenous (IV) loading dose followed by a continuous IV infusion in preterm subjects, ages ≥ 28 weeks through \< 36 weeks gestational age.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia#1369492
- Dexmedetomidine in Mechanically Ventilated Neonates With Single-Organ Respiratory Failure.#1282573
- Dexamethasone Therapy in VLBW Infants at Risk of CLD#848136
- Sufentanil Pharmacokinetics After Intra Amniotic Injection#1172043
- Dexmedetomidine Versus Propofol for Sedation During Awake Endotracheal Intubation#903986
Record · ID 1364609
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive